[Modification of collagen metabolism by antirheumatic agents as a therapeutic principle].
D000818:Animals; D002247:Carbon Isotopes; D003094:Collagen / Q000378:metabolism*; D003436:Croton Oil / Q000494:pharmacology; D005110:Extracellular Space; D006097:Granulation Tissue / Q000032:analysis; D006099:Granuloma / Q000209:etiology / Q000503:physiopathology*; D006909:Hydroxyproline / Q000032:analysis / Q000378:metabolism; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008854:Microscopy, Electron; D010113:Oxyphenbutazone / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology*; D051381:Rats
D002247:Carbon Isotopes; D007527:Isoenzymes; D003436:Croton Oil; D003094:Collagen; D007770:L-Lactate Dehydrogenase; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D006909:Hydroxyproline
Beeinflussung des Kollagenstoffwechsels durch Antireuamtika als therapeutisches Prinzip.